Clinical Trials
28
Active:0
Completed:20
Trial Phases
2 Phases
Phase 2:8
Phase 3:16
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials
Phase 3
16 (57.1%)Phase 2
8 (28.6%)phase_2_3
4 (14.3%)Effect of Probiotic Lozenge on Gingivitis and Periodontitis
Phase 3
Completed
- Conditions
- Mild and Moderate Chronic Periodontitis
- Interventions
- Drug: Placebo ArmDrug: Probiotic Arm
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- CD Pharma India Pvt. Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT02203812
- Locations
- 🇮🇳
Department of Periodontology, Government Dental College & Hospital, Vijayawada, Andra Pradesh, India
Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis
- First Posted Date
- 2014-06-26
- Last Posted Date
- 2014-12-15
- Lead Sponsor
- CD Pharma India Pvt. Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02174757
- Locations
- 🇮🇳
Dept. of Periodontics and Implantology, Sree Mookambika Institute of Dental Sciences, Kulasekharam, Tamil Naidu, India
Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients.
Phase 3
Completed
- Conditions
- Chronic Periodontitis
- Interventions
- Drug: PlaceboDrug: Probiotic (Inersan)
- First Posted Date
- 2014-04-23
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- CD Pharma India Pvt. Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT02121665
- Locations
- 🇮🇳
Department of Periodontics, Government Dental College & Hospital, Aurangabad, Maharashtra, India
Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis
Phase 3
Completed
- Conditions
- Chronic Periodontitis
- Interventions
- Drug: Probiotic (Inersan)Drug: Placebo
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2014-07-23
- Lead Sponsor
- CD Pharma India Pvt. Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT01870362
- Locations
- 🇮🇳
Mahatma Gandhi Post Graduate Institute of Dental Sciences (MGPGI), Puducherry, India
Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Phase 2
Completed
- Conditions
- Hepatic Encephalopathy
- Interventions
- Drug: VSL#3Other: Placebo
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2013-12-30
- Lead Sponsor
- CD Pharma India Pvt. Ltd.
- Target Recruit Count
- 130
- Registration Number
- NCT01110447
- Locations
- 🇮🇳
Dept. of Hepatology, PGIMER, Chandigarh, India
- Prev
- 1
- 2
- Next
News
No news found